Skip to content

Effect of a Unique Web-based Behaviour Change Program on Weight Loss and Cardiovascular Risk Factors

Effect of a Unique Web-based Behaviour Change Program for Physical Activity and Weight Management on Weight Loss and Cardiovascular Risk Factors in Overweight or Obese Adults at High Risk of Cardiovascular Disease

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01472276
Enrollment
65
Registered
2011-11-16
Start date
2011-04-30
Completion date
2013-03-31
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Behaviour change, Weight loss, Cardiovascular risk, Diet, Physical activity, Overweight, Obesity, Internet

Brief summary

Web- or internet-based programs have the potential to induce and, possibly, help to sustain, significant lifestyle modification. This study will evaluate the effect of a unique interactive web-based behaviour change program on weight loss and cardiovascular risk factors in people who are overweight or obese and at high risk of cardiovascular disease.

Interventions

BEHAVIORALWeb-based program

Provided with the web-based program

Sponsors

AXA PPP Healthcare
CollaboratorINDUSTRY
Queen's University, Belfast
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years old * Have regular access to the internet, telephone and have an e-mail address. * Body mass index (BMI) greater than 27 and less than 40 * Sedentary * Have one or more of the following risk factors associated with cardiovascular disease: Elevated blood pressure ≥ 140 mm Hg systolic or ≥ 90 mm Hg diastolic; Elevated total cholesterol ≥ 5.0; Type 2 diabetes * Be willing to refrain from participating in another behaviour change program for the duration of the study

Exclusion criteria

* Major health problems including Type 1 diabetes, established CVD, renal and hepatic disease * Psychiatric problems * Pregnancy * Excessive alcohol consumption

Design outcomes

Primary

MeasureTime frameDescription
Weight Loss Kg3 monthsBetween-group change in weight loss at 3-month follow-up

Secondary

MeasureTime frameDescription
Physical Activity3 months, 6 months, 12 monthsAssessed by triaxial accelerometer and RPAQ questionnaire
Blood Pressure (Seated, Systolic and Diastolic mmHg)3 months, 6 months, 12 monthsSeated, systolic and diastolic mmHg
Biochemical Markers of CVD Risk3 months, 6 months, 12 monthsTotal cholesterol HDL cholesterol, LDL cholesterol, triglycerides high-sensitivity CRP, HOMA, HbA1c
Dietary Intake3 months, 6 months, 12 monthsDiet history
Pulse Wave Analysis3 months, 6 months, 12 monthsSpygmoCor Pulse Wave Analysis System
Weight Loss6 months and 12 monthsBetween-group change in weight loss at 6 and 12 months
Sleep Quality3 months, 6 months, 12 monthsQuestionnaire
Self-esteem3 months, 6 months, 12 monthsQuestionnaire
Self-efficacy3 months, 6 months, 12 monthsQuestionnaire
Depression3 months, 6 months, 12 monthsQuestionnaire
Quality of Life3 months, 6 months, 12 monthsQuestionnaire

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Control33
Web-based Program
Web-based program: Provided with the web-based program
32
Total65

Baseline characteristics

CharacteristicControlWeb-based ProgramTotal
Age, Continuous52.9 years
STANDARD_DEVIATION 7.27
51.4 years
STANDARD_DEVIATION 7.59
52.1 years
STANDARD_DEVIATION 7.4
Sex: Female, Male
Female
20 Participants16 Participants36 Participants
Sex: Female, Male
Male
13 Participants16 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 330 / 32
serious
Total, serious adverse events
0 / 330 / 32

Outcome results

Primary

Weight Loss Kg

Between-group change in weight loss at 3-month follow-up

Time frame: 3 months

Population: Weight (kg) outcome differences within study groups from baseline to 3 months (complete-case analysis).

ArmMeasureValue (MEAN)
ControlWeight Loss Kg-0.53 kg
Web-based ProgramWeight Loss Kg-4.37 kg
Secondary

Biochemical Markers of CVD Risk

Total cholesterol HDL cholesterol, LDL cholesterol, triglycerides high-sensitivity CRP, HOMA, HbA1c

Time frame: 3 months, 6 months, 12 months

Secondary

Blood Pressure (Seated, Systolic and Diastolic mmHg)

Seated, systolic and diastolic mmHg

Time frame: 3 months, 6 months, 12 months

Secondary

Depression

Questionnaire

Time frame: 3 months, 6 months, 12 months

Secondary

Dietary Intake

Diet history

Time frame: 3 months, 6 months, 12 months

Secondary

Physical Activity

Assessed by triaxial accelerometer and RPAQ questionnaire

Time frame: 3 months, 6 months, 12 months

Secondary

Pulse Wave Analysis

SpygmoCor Pulse Wave Analysis System

Time frame: 3 months, 6 months, 12 months

Secondary

Quality of Life

Questionnaire

Time frame: 3 months, 6 months, 12 months

Secondary

Self-efficacy

Questionnaire

Time frame: 3 months, 6 months, 12 months

Secondary

Self-esteem

Questionnaire

Time frame: 3 months, 6 months, 12 months

Secondary

Sleep Quality

Questionnaire

Time frame: 3 months, 6 months, 12 months

Secondary

Weight Loss

Between-group change in weight loss at 6 and 12 months

Time frame: 6 months and 12 months

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026